Acute Monocytic Leukemia — Trials

Acute Monocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

85 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06950034	A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)	recruiting	Phase 1	105	Solu Therapeutics, IncINDUSTRY	1	Feb 9, 2026	clinicaltrials
NCT06429449	Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia	recruiting	Phase 1	30	University of Colorado, DenverOTHER	1	Jan 15, 2026	clinicaltrials